Myocarditis surgery: Difference between revisions
No edit summary |
Homa Najafi (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Myocarditis}} | {{Myocarditis}} | ||
{{CMG}} | {{CMG}}{{AE}}{{Homa}} | ||
==Overview== | ==Overview== | ||
Line 7: | Line 7: | ||
==Surgery== | ==Surgery== | ||
[[Cardiac transplantation]] is sometimes required to treat refractory [[giant cell myocarditis]]. However, the condition can recur in post-transplant patients.<ref name="pmid9197214">{{cite journal| author=Cooper LT, Berry GJ, Shabetai R| title=Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. | journal=N Engl J Med | year= 1997 | volume= 336 | issue= 26 | pages= 1860-6 | pmid=9197214 | doi=10.1056/NEJM199706263362603 | pmc= | url= }} </ref> | [[Cardiac transplantation]] is sometimes required to treat refractory [[giant cell myocarditis]]. However, the condition can recur in post-transplant patients.<ref name="pmid9197214">{{cite journal| author=Cooper LT, Berry GJ, Shabetai R| title=Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. | journal=N Engl J Med | year= 1997 | volume= 336 | issue= 26 | pages= 1860-6 | pmid=9197214 | doi=10.1056/NEJM199706263362603 | pmc= | url= }} </ref> | ||
==Overview== | |||
Surgical intervention is not recommended for the management of [disease name]. | |||
OR | |||
Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either [indication 1], [indication 2], and [indication 3] | |||
OR | |||
The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3]. | |||
OR | |||
The feasibility of surgery depends on the stage of [malignancy] at diagnosis. | |||
OR | |||
Surgery is the mainstay of treatment for [disease or malignancy]. | |||
==Indications== | |||
*Surgical intervention is not recommended for the management of [disease name]. | |||
OR | |||
*Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either: | |||
**[Indication 1] | |||
**[Indication 2] | |||
**[Indication 3] | |||
*The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either: | |||
**[Indication 1] | |||
**[Indication 2] | |||
**[Indication 3] | |||
==Surgery== | |||
*The feasibility of surgery depends on the stage of [malignancy] at diagnosis. | |||
OR | |||
*Surgery is the mainstay of treatment for [disease or malignancy]. | |||
==Contraindications== | |||
==References== | ==References== |
Revision as of 04:37, 23 December 2019
Myocarditis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Myocarditis surgery On the Web |
American Roentgen Ray Society Images of Myocarditis surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]
Overview
Cardiac transplantation is sometimes required to treat refractory giant cell myocarditis. However, the condition can recur in post-transplant patients.[1]
Surgery
Cardiac transplantation is sometimes required to treat refractory giant cell myocarditis. However, the condition can recur in post-transplant patients.[1]
Overview
Surgical intervention is not recommended for the management of [disease name].
OR
Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either [indication 1], [indication 2], and [indication 3]
OR
The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].
OR
The feasibility of surgery depends on the stage of [malignancy] at diagnosis.
OR
Surgery is the mainstay of treatment for [disease or malignancy].
Indications
- Surgical intervention is not recommended for the management of [disease name].
OR
- Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either:
- [Indication 1]
- [Indication 2]
- [Indication 3]
- The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either:
- [Indication 1]
- [Indication 2]
- [Indication 3]
Surgery
- The feasibility of surgery depends on the stage of [malignancy] at diagnosis.
OR
- Surgery is the mainstay of treatment for [disease or malignancy].